CN1058622C - Rehabilitation powder for hepatitis B - Google Patents
Rehabilitation powder for hepatitis B Download PDFInfo
- Publication number
- CN1058622C CN1058622C CN96115315A CN96115315A CN1058622C CN 1058622 C CN1058622 C CN 1058622C CN 96115315 A CN96115315 A CN 96115315A CN 96115315 A CN96115315 A CN 96115315A CN 1058622 C CN1058622 C CN 1058622C
- Authority
- CN
- China
- Prior art keywords
- radix
- hepatitis
- root
- fructus
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a rehabilitation powder for treating hepatitis B, which belongs to Chinese patent medicine for treating hepatitis B. The medicine is prepared from 4 to 7g of stringy stonecrop, 4 to 7g of rice sprout, 4 to 7g of edible amaranth, 4 to 7g of green bean, 4 to 7g of artemisiae scopariae, 3 to 5g of Chinese magnoliavine fruit, 3 to 5g of bupleurum root, 3 to 5g of atractylodes rhizome, 3 to 5g of hawthorn, 3.5 to 5.5g of alkanna tinctoria, 3.5 to 5.5g of imperatae rhizome, 3.5 to 5.5g of forsythia fruit, 3.5 to 5.5g of honeysuckle flower, 3.5 to 5.5g of poria coco, 3.5 to 5.5g of red peony root, 3.5 to 5.5g of coptis root, 3.5 to 5.5g of angelica root, 3.5 to 5.5g of ganoderma lucidum and 3.5 to 5.5g of red sage root. The rehabilitation powder for treating hepatitis B has good curative effect on hepatitis B, the negative conversion rate can reach 89%, and the effective rate can reach 100%.
Description
The invention belongs to a kind of Chinese patent medicine for the treatment of hepatitis B.
Hepatitis is a kind of infectious disease in the our times scope, wherein hepatitis B patient and carrier in China up to people more than 100,000,000, according to interrelated data statistics, being with has 40% or highlyer give ewborn infant by the Placenta Hominis vertical transmission among malicious mother, influence people's of future generation physical and mental health.Hepatitis B easily transfers chronic hepatitis to, liver cirrhosis, even hepatocarcinoma.Therefore, hepatitis B is one of able-bodied main infectious disease of harm humans.The Chinese patent medicine kind of treatment hepatitis B is more at present, as Yiganling, hepatitis B health electuary, middle imperial liver spleen health etc.Show that according to clinical observation treatment take above-mentioned medicine treatment hepatitis B disease, the hepatitis B virus negative conversion rate is about about 60%, so curative effect is not ideal enough.
Purpose of the present invention provides and is a kind ofly made the rehabilitation powder for hepatitis B that the treatment hepatitis B has a very high curative effect by natural Chinese medicinal herb.
The compatibility of rehabilitation powder for hepatitis B is: every 100g includes crude drug Herba Sedi 4-7g, Fructus Setariae Germinatus 4-7g, three-coloured amaranth 4-7g, Semen phaseoli radiati 4-7g, Herba Artemisiae Scopariae 4-7g, Fructus Schisandrae Chinensis 3-5g, Radix Bupleuri 3-5g, Rhizoma Atractylodis 3-5g, Fructus Crataegi 3-5g, Radix Arnebiae (Radix Lithospermi) 3.5-5.5g, Cymbidium ensifolium (L.) Sw. root 3.5-5.5g, Fructus Forsythiae 3.5-5.5g, Flos Lonicerae 3.5-5.5g, Poria 3.5-5.5g, Radix Paeoniae Rubra 3.5-5.5g, Rhizoma Coptidis 3.5-5.5g, Radix Angelicae Sinensis 3.5-5.5g, Ganoderma 3.5-5.5g, Radix Salviae Miltiorrhizae 3.5-5.5g.
Embodiment:
Rehabilitation powder for hepatitis B, every 100g include crude drug Herba Sedi 5g, Fructus Setariae Germinatus 5g, three-coloured amaranth 5g, Semen phaseoli radiati 5g, Herba Artemisiae Scopariae 5g, Fructus Schisandrae Chinensis 4g, Radix Bupleuri 4g, Rhizoma Atractylodis 4g, Fructus Crataegi 4g, Radix Arnebiae (Radix Lithospermi) 5g, Cymbidium ensifolium (L.) Sw. root 5g, Fructus Forsythiae 5g, Flos Lonicerae 5g, Poria 5g, Radix Paeoniae Rubra 5g, Rhizoma Coptidis 5g, Radix Angelicae Sinensis 5g, Ganoderma 5g, Radix Salviae Miltiorrhizae 5g.
Rehabilitation powder for hepatitis B, be mixed with by above-mentioned natural Chinese medicinal herb, immunocompetence with heat-clearing and toxic substances removing, liver-smoothing, qi-regulating, blood circulation promoting and blood stasis dispelling, enhancing body, promote the effects such as liver spleen that fibrous tissue heavily absorbs and dwindle enlargement, can reach 89% through Kaiyuan City institute of traditional Chinese medicine to hepatitis B patient clinical treatment proof negative conversion rate, effective percentage reaches 100%, welcome by the patient.
Rehabilitation powder for hepatitis B, be that I treat the summary of hepatitis practice experience over more than 30 year, from medical practice, filter out prescription evident in efficacy, each Chinese medicine has been carried out chemical analysis analysis and curative effect demonstration again, and make powder, except that oneself doing the clinical case observation, please Kaiyuan City institute of traditional Chinese medicine make clinical treatment observation again, prove that all rehabilitation powder for hepatitis B is highly effective to the treatment hepatitis B.According to the interrelated data statistics, hepatitis B patient reaches 6-7 hundred million people both at home and abroad at present, and promoting the use of rehabilitation powder for hepatitis B not only has considerable economic benefit, and remarkable social benefit is arranged.
The manufacture method of rehabilitation powder for hepatitis B:
1, with Herba Sedi, Fructus Setariae Germinatus, three-coloured amaranth, Semen phaseoli radiati, Herba Artemisiae Scopariae, Fructus Schisandrae Chinensis, Radix Bupleuri, Rhizoma Atractylodis, Fructus Crataegi, Radix Arnebiae (Radix Lithospermi), Cymbidium ensifolium (L.) Sw. root, Fructus Forsythiae, Flos Lonicerae, Poria, Radix Paeoniae Rubra, Rhizoma Coptidis, Radix Angelicae Sinensis, Ganoderma, Radix Salviae Miltiorrhizae, remove impurity respectively, through cleaning, dry, pulverizing, after crossing 120 mesh sieves, that the medicated powder preserve separately that obtains is standby:
2, said herbal medicine is chosen by proportion compatibility, and behind the mix homogeneously, used ultraviolet radiation sterilization, be the rehabilitation powder for hepatitis B finished product.
Rehabilitation powder for hepatitis B of the present invention can incapsulate, and makes the hepatitis B recuperating medicine capsule.As No. 0 capsule.Also can be made into pill or tablet.
Claims (2)
1, rehabilitation powder for hepatitis B is characterized in that the compatibility of this medicine is:
Every 100g includes crude drug Herba Sedi 4-7g, Fructus Setariae Germinatus 4-7g, three-coloured amaranth 4-7g, Semen phaseoli radiati 4-7g, Herba Artemisiae Scopariae 4-7g, Fructus Schisandrae Chinensis 3-5g, Radix Bupleuri 3-5g, Rhizoma Atractylodis 3-5g, Fructus Crataegi 3-5g, Radix Arnebiae (Radix Lithospermi) 3.5-5.5g, Cymbidium ensifolium (L.) Sw. root 3.5-5.5g, Fructus Forsythiae 3.5-5.5g, Flos Lonicerae 3.5-5.5g, Poria 3.5-5.5g, Radix Paeoniae Rubra 3.5-5.5g, Rhizoma Coptidis 3.5-5.5g, Radix Angelicae Sinensis 3.5-5.5g, Ganoderma 3.5-5.5g, Radix Salviae Miltiorrhizae 3.5-5.5g.
2, rehabilitation powder for hepatitis B according to claim 1 is characterized in that the compatibility of this medicine is:
Every 100g includes crude drug Herba Sedi 5g, Fructus Setariae Germinatus 5g, three-coloured amaranth 5g, Semen phaseoli radiati 5g, Herba Artemisiae Scopariae 5g, Fructus Schisandrae Chinensis 4g, Radix Bupleuri 4g, Rhizoma Atractylodis 4g, Fructus Crataegi 4g, Radix Arnebiae (Radix Lithospermi) 5g, Cymbidium ensifolium (L.) Sw. root 5g, Fructus Forsythiae 5g, Flos Lonicerae 5g, Poria 5g, Radix Paeoniae Rubra 5g, Rhizoma Coptidis 5g, Radix Angelicae Sinensis 5g, Ganoderma 5g, Radix Salviae Miltiorrhizae 5g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96115315A CN1058622C (en) | 1996-05-17 | 1996-05-17 | Rehabilitation powder for hepatitis B |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96115315A CN1058622C (en) | 1996-05-17 | 1996-05-17 | Rehabilitation powder for hepatitis B |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1145802A CN1145802A (en) | 1997-03-26 |
CN1058622C true CN1058622C (en) | 2000-11-22 |
Family
ID=5122588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96115315A Expired - Fee Related CN1058622C (en) | 1996-05-17 | 1996-05-17 | Rehabilitation powder for hepatitis B |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1058622C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100346800C (en) * | 2004-11-08 | 2007-11-07 | 北京万邦医药投资有限公司 | Chinese medicine composition for preventing and treating hepatitis |
CN100387246C (en) * | 2005-10-31 | 2008-05-14 | 北京万赛生物医药技术发展有限公司 | Pharmaceutical composition for treating liver disease and its preparation and application |
-
1996
- 1996-05-17 CN CN96115315A patent/CN1058622C/en not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
《中医药研究》(6) 1994.1.1 张家辉."丹芪行水汤为主治疗肝炎后肝硬化腹水581例" * |
《湖北中医杂志》(2) 1983.1.1 肖新华"治疗急性黄胆型肝炎230例" * |
《黑龙江中医药》,(2) 1985.1.1 宋文海等肝炎用药琐谈 * |
《黑龙江中医药》,(2) 1985.1.1 宋文海等肝炎用药琐谈;《湖北中医杂志》(2) 1983.1.1 肖新华"治疗急性黄胆型肝炎230例";《中医药研究》(6) 1994.1.1 张家辉."丹芪行水汤为主治疗肝炎后肝硬化腹水581例" * |
Also Published As
Publication number | Publication date |
---|---|
CN1145802A (en) | 1997-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101129817B (en) | Chinese medicine formulation for treating hypertension and method of producing the same | |
CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
CN100998838A (en) | Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof | |
CN1204523A (en) | Prescription of dispelling wind and strengthening bone wine and preparation method | |
CN1245707A (en) | Chinese medicine for curing AIDS and carcinomatosis | |
CN110960619A (en) | Traditional Chinese medicine composition for treating African swine fever | |
CN1304744A (en) | Chinese medicine for curing hepatitis B and cirrhosis ascites | |
CN101041036A (en) | Medicine liquid for reducing pain for external application | |
CN102038911A (en) | Traditional Chinese medicine preparation for treating acute mastitis | |
CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
CN102727779A (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
CN101623352A (en) | Medicine for treating acne and preparation method thereof | |
CN101361896B (en) | Traditional Chinese medicine composition for treating viscera inflammation | |
CN1218706C (en) | Hepatitis B treaitng pill | |
CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
CN1058622C (en) | Rehabilitation powder for hepatitis B | |
CN1071123C (en) | Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites | |
CN102335336A (en) | Traditional Chinese medicine for treating lupus sebaceus | |
CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
CN1227022C (en) | Capsule for treating epidemic parotitis | |
CN101085088A (en) | Traditional Chinese medicine formula for treating prostatic hyperplasia | |
CN108014303A (en) | A kind of Chinese medicine preparation for treating Ru Repair-in and preparation method thereof | |
CN100411666C (en) | Broad-specturm medicine for treating snake venom poisoning | |
CN102895495B (en) | Traditional Chinese medicine for treating tuberculous lymphadenitis | |
CN1408384A (en) | Pure traditional Chinese medicine preparation for curing lung cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |